BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22577589)

  • 1. The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.
    Spirig R; Tsui J; Shaw S
    Cardiol Res Pract; 2012; 2012():181394. PubMed ID: 22577589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.
    Lin E; Freedman JE; Beaulieu LM
    Cardiovasc Ther; 2009; 27(2):117-23. PubMed ID: 19426249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease.
    Bezhaeva T; Karper J; Quax PHA; de Vries MR
    Front Cardiovasc Med; 2022; 9():820962. PubMed ID: 35237675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors in angiogenesis.
    Grote K; Schütt H; Schieffer B
    ScientificWorldJournal; 2011 Apr; 11():981-91. PubMed ID: 21516292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction.
    Navi A; Patel H; Shaw S; Baker D; Tsui J
    Vascul Pharmacol; 2013 Mar; 58(3):231-9. PubMed ID: 23070056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
    Curtiss LK; Tobias PS
    Curr Drug Targets; 2007 Dec; 8(12):1230-8. PubMed ID: 18220700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
    Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
    Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats.
    Bhaskar S; Helen A
    Mol Cell Biochem; 2016 Dec; 423(1-2):53-65. PubMed ID: 27665434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR signalling and association of TLR polymorphism with cardiovascular diseases.
    Sharma S; Garg I; Ashraf MZ
    Vascul Pharmacol; 2016 Dec; 87():30-37. PubMed ID: 27826031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Yin and Yang of toll-like receptors in endothelial dysfunction.
    Deravi N; Poudineh M; Pirzadeh M; Yavarpour-Bali H; Mehrabi H; Erabi G; Saghazadeh A; Rezaei N
    Int Immunopharmacol; 2022 Jul; 108():108768. PubMed ID: 35430433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Receptors, Key Actors in Cardiovascular Diseases.
    Jaén RI; Val-Blasco A; Prieto P; Gil-Fernández M; Smani T; López-Sendón JL; Delgado C; Boscá L; Fernández-Velasco M
    JACC Basic Transl Sci; 2020 Jul; 5(7):735-749. PubMed ID: 32760860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important aspects of Toll-like receptors, ligands and their signaling pathways.
    Chang ZL
    Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.
    Chao W
    Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H1-12. PubMed ID: 19011041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of toll-like receptors by insulin.
    Tilich M; Arora RR
    Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.